Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Finasteride given to baby rats causes anxiety-like behavior and worsens learning from punishment in adult rats.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Acne is an important sign of androgen excess disorders in women.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Women with PCOS often have liver disease, so liver health checks are important for them.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.